More expansion for QPS in Asia through intellim JV
QPS Holdings has set up a joint venture (JV) partnership with intellim Corporation to set up a new CRO in Japan.
QPS Holdings has set up a joint venture (JV) partnership with intellim Corporation to set up a new CRO in Japan.
Quintiles expects to support Alimera Sciences’ efforts to gain UK approval for a diabetic vision loss treatment already deemed too expensive by NICE.
correction
Drugmaker Pfizer is on the list of 74 firms that have not paid their share of the $50m ‘backlog’ fee required under the Generic Drug User Fee Amendments (GDUFA) law.
Showa Denko KK (SDK) wants a share of the of the biopharmaceutical resins sector and has partnered with purification tech firm BIA Separations (BIASep) to get it.